Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Croda, Michelmersh Brick

(Sharecast News) - Speciality chemicals firm Croda surged on Wednesday as Morgan Stanley upgraded the stock to 'overweight' from 'equalweight' and lifted its price target to 3,350p from 3,280p as it pointed to pricing agility ahead of peers. Morgan Stanley said investors have mixed views about Croda's pricing ability, given historical competitive pressures through the 2021/22 inflationary cycle and price-mix negatives in 2025, to drive operational gearing.

"However, Croda performs particularly well in an inflationary cycle, passing through input inflation across its portfolio typically at circa 1 quarter lag to higher raw materials increases - faster than peers typically requiring circa 2 quarters - thereby broadly tracking its inventory levels (circa 2.6 months)," it said.

"As a result, we believe Croda will be one of the fastest players to pass on input inflation to customers (noting that most of its ingredients represent a single-digit percentage of total customer production costs), offering absolute profit protection."

The bank also noted that Croda was one of the few ingredient names with limited/no downside risk to FY26 adjusted earnings per share consensus estimates, and said it now offers superior 2026 LFL/adjusted EPS growth prospects to most.

Morgan Stanley lifted its FY25/26/27 EPS estimates by 4.0%/+3.6%/+3.7%. respectively. to reflect higher pricing, slightly lower volumes - mainly across consumer care and industrial specialties - and slightly lower FX negatives.

Analysts at Berenberg lowered their target price on Michelmersh Brick Holdings from 150p to 120p on Wednesday, but noted the firm has been succesful in maintaining market share amid "customer uncertainty".

Michelmersh released its FY25 results on 24 March, reporting underlying earnings that were broadly in line with Berenberg's forecasts and revealed that it had maintained its UK market share during the year amid gradually rising volumes, customer uncertainty and "a highly competitive" pricing environment, as industry production increased. However, the German bank noted that market conditions in Belgium had "remained challenging".

Although Berenberg expects the group to see EBITDA increase further in FY26, it also said was "cognisant of ongoing headwinds" relating to pricing pressure and customer uncertainty.

"We expect that the challenges that the group faced in FY25 will continue into FY26, given the ongoing uncertainty regarding momentum in the UK construction industry and the Belgian brick market. The conflict in Iran has further affected consumer confidence, extending this period of uncertainty, in our view, although we note that the group has already secured 75% of its energy requirements for FY26, limiting its exposure to energy price volatility," said Berenberg.

"As such, we have lowered our EBITDA forecasts for 2026-28 by 3-5%. We have also lowered our price target from 150p to 120p, but maintain our 'buy' rating."

Share this article

Related Sharecast Articles

Broker tips: 3i Group, YouGov
(Sharecast News) - Citi reiterated its 'buy' rating on 3i Group on Tuesday and opened an 'upside catalyst watch' on the shares as it noted that slowing like-for-like growth at portfolio holding Action has driven 40% underperformance in the past six months.
Broker tips: Croda International, Smiths Group
(Sharecast News) - Croda International sparked on Monday after Goldman Sachs double-upgraded the shares to 'buy' from 'sell' as it said the speciality chemicals firm's own market-recovery actions have delivered organic sales growth ahead of expectations.
Broker tips: Diploma, Wickes
(Sharecast News) - Analysts at Berenberg hiked their target price on technical products and services firm Diploma from 6,600p to 7,500p on Thursday following the firm's unscheduled trading update a day earlier.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.